Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study.Courtney D DiNardo,Stéphane De Botton,Daniel A Pollyea,Richard M Stone,Jessica K Altman,Amir T Fathi, Tharin Limsakun, Min Liang,Sung Choe,Mohammad Hossain,Adriana E Tron,Qian Meng,Stephanie M Kapsalis,Shuchi S Pandya,Eytan M SteinAmerican journal of hematology（2023）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
